Summary of the leading positionic and critical facts

Modafresh is a brand name for modafinil, a prescription medicine used to promote wakefulness in adults with excessive daytime sleepiness. It reduces the symptom of sleepiness but does not cure underlying disorders. Continue condition specific treatments, for example CPAP for obstructive sleep apnoea, while taking Modafresh. It is best to refer to the product label for dosing informational content. the section detailing dosage at dose and method of administration advice.

Brand discussed

Modafresh

Active substance

Modafinil

Usual indicators

Narcolepsy as a medical condition, residual sleepiness despite OSA therapy, shift work sleep disorder

Typical tablet strengths

100 mg and 200 mg tablets

Quick navigation to see more tracking interpersonal engagements helps measure engagement., price catalog guide or notes for legal purposes for additional details.

Traces and clinical applications

Modafinil is prescribed by clinicians to improve daytime alertness in adults with documented sleep disorders. Typical uses include:

• The disorder known as narcolepsy, with or without cataplexy
• Persistent excessive sleepiness in obstructive sleep apnoea after primary therapy has been optimised
• Shift work sleep disorder, to help maintain wakefulness during scheduled work periods

Bear in mind that modafinil treats the symptom of sleepiness rather than the cause. It should be used alongside other appropriate therapies and lifestyle measures for the underlying disorder.

Dosing regimen and administration advice

Always follow the administration instructions for dosing given by your prescriber. Typical adult regimens are as follows:

• Narcolepsy syndrome or OSA related daytime sleepiness: commonly 200 mg once every morning.
• Shift work sleep disorder: often 200 mg taken about one hour before the start of the work shift.

It is okay to take tablets with or without food. Avoid taking Modafresh late in the day if it makes it hard to sleep at night. Older patients and people with significant liver impairment may need lower doses or specialist review; ask your prescriber for personalised backing and guidance.

Safety readiness before starting treatment

Before you kick off Modafresh, tell your healthcare professional about any relevant medical history, particularly:

• Heart disease such as coronary artery disease, angina, prior myocardial infarction, uncontrolled high blood pressure or structural heart problems
• Decline in kidney or liver function, including cirrhosis
• History of mood disorders, psychosis, bipolar disorder, anxiety or substance misuse
• Plan for pregnancy, current pregnancy or breastfeeding

Modafinil can reduce the effectiveness of hormonal contraceptives. Use an additional reliable contraceptive while taking Modafresh and for at least two months after stopping. See medicines communication in action concerns for more on contraceptives.

Be cautious with driving or operating machinery until you know how Modafresh affects you, especially when starting treatment or after dose changes.

When this should not be used and exclusions

Do not use Modafresh if any of the following apply to you:

• Known hypersensitivity to modafinil, armodafinil or any other ingredient in the product
• Age below 17 years; modafinil is not licensed for use in this age group in the UK

Avoid alcohol while taking Modafresh. Do not undertake activities that require full alertness until you are sure the medicine does not impair your abilities.

Likely adverse reactions to stay alert for for

Commonly reported collateral effects include:

• The pain in the head and dizziness
• Increased anxiety or nervousness
• Nausea, abdominal pain or diarrhoea
• Sleeplessness, nasal congestion, back pain

Serious reactions are rare but can occur. Seek urgent medical attention if you develop severe skin rashes, swelling of the face or throat, chest pain, hallucinations or thoughts of self harm. Weight changes may occur secondary to appetite changes.

The influence of food on drug action

Give your clinician a full list of prescribed medicines, over the counter drugs, vitamins and herbal remedies. Influential exchanges include:

• Drugs metabolised by CYP3A4: modafinil can lower their levels. Examples include many combined hormonal contraceptives, cyclosporine, midazolam and triazolam. Extra contraceptive protective measures or monitoring and logging may be necessary.
• Drugs metabolised by CYP2C19: modafinil may increase levels of medicines such as phenytoin, diazepam, propranolol and omeprazole; dose adjustment or active monitoring may be needed.
• Warfarin: modafinil can affect INR; arrange closer INR checks when starting or stopping Modafresh.
• Monoamine oxidase inhibitors: coadministration is usually not recommended without specialist advice.

Caffeine, nicotine and other stimulants can make unintended effects like jitteriness, palpitations or insomnia worse. Discuss any oral contraceptives or anticoagulants you use with your prescriber to consider monitoring of operational health or several options.

Handling guidance for dose was skippeds

If you have missed a dose, do not take a double dose to catch up. If taking the i skipped a dose today would interfere with sleep or be close to bedtime, skip it and continue with your usual schedule the next day.

Procedures for drug overdose and emergency responses

Excess dose of a drug may cause agitation, restlessness, fast heart rate, high blood pressure, tremor, severe insomnia or nausea. In the UK, seek immediate medical attention for a suspected a fatal overdose. For life threatening emergencies call 999; for urgent but non life threatening advice contact NHS 111.

Safe keeping and disposal

Store Modafresh in its original container at normal room temperature and keep it away from excess heat and moisture. Ensure medications remain out of reach and out of sight of children and pets. Return unused or expired medicines to a pharmacy for safe disposal rather than throwing them in household waste where possible.

Comparative review of other possibilities

Several other options exist for excessive daytime sleepiness and narcolepsy. Choices depend on diagnosis, presence of cataplexy, side effect profile, real time engagement and communications enable quick problem solving. and cost. Common optional choices include:

• Generic modafinil or other modafinil brands such as Provigil - same active ingredient, availability and price may vary.
• Armodafinil - the R enantiomer of modafinil; available in some countries, limited availability in the UK.
• Solriamfetol (Sunosi) - a dopamine and norepinephrine reuptake inhibitor licensed in the UK for narcolepsy and OSA related sleepiness.
• Pitolisant (Wakix) - a histamine H3 receptor inverse agonist used for narcolepsy, sometimes helpful for cataplexy.
• Sodium oxybate products (Xyrem, Xywav) - specialist option for cataplexy and disturbed nighttime sleep in narcolepsy; supply is restricted.
• Traditional stimulants such as methylphenidate or dexamfetamine - used under specialist supervision when further treatment options are unsuitable.

Discuss the relative benefits, risks and costs of these options with your specialist to find the best individual choice.

Typical price bands in the UK in GBP - approximate guide

Private costs vary with supplier, pack size and whether the product is branded or generic. The figures below are approximate and intended only as a rough guide for private purchase:

• Generic modafinil 100 mg: about 0.80 to 2 in descending steps.50 per tablet; a 30 day supply may cost roughly 24 to 75 plus any pharmacy fees.
• Generic modafinil 200 mg: around 1.20 to 3.50 per tablet; monthly private costs often fall between 36 and 105.
• Solriamfetol (Sunosi): monthly private cost commonly ranges from about 60 to 140 depending on dose.
• Pitolisant (Wakix): private prices are frequently several hundred pounds per month, often in the 200 to 700 range depending on dose.
• Sodium oxybate products: very high cost and usually supplied through specialist NHS routes or named patient arrangements rather than routine private purchase.

On the NHS, prescriptions and funding vary across the UK. In England many adults pay a fixed charge per item unless exempt; in Scotland, Wales and Northern Ireland most NHS prescriptions are free. Local formularies determine which medicines are routinely funded.

United Kingdom regulatory and legal considerations framework summary

• Prescription only medicine: Modafinil is a POM in the UK and must be supplied only with a valid prescription.
• Not a controlled drug: Modafinil is not scheduled under the Misuse of Drugs Act, but sale and supply are regulated.
• Online purchases: Use UK registered pharmacies. Legitimate distance selling pharmacies are regulated by the General Pharmaceutical Council and should be registered with the MHRA.
• Import rules: Importing prescription medicines for personal use without a valid UK prescription can lead to seizure by Border Force and may breach regulations.
• Driving: People with narcolepsy or significant daytime sleepiness should follow DVLA consistent guidance. Do not drive if the medicine causes drowsiness or impairs driving ability.
• Sport: Modafinil is a prohibited stimulant under WADA. Athletes should check UK Anti Doping requirements and consider therapeutic use exemptions if appropriate.
• Adverse event reporting: Report suspected incidental outcomes to the MHRA via the Yellow Card scheme.

If you are unsure about lawful supply routes or safe options for obtaining Modafresh, consult your pharmacist or prescribing clinician.